|
WO2021041374A1
|
|
Liposome formulation of fluticasone furoate and method of preparation
|
|
WO2021021879A1
|
|
Cartridge with single-layer container and its nozzle-shaped cap for nebulization inhalation
|
|
US2021030868A1
|
|
Formulation of antibody based drugs for treating lung cancer by inhalation
|
|
US2020405700A1
|
|
Inhalable formulation of a solution containing formoterol fumarate and aclidinium bromide
|
|
US2020375945A1
|
|
Inhalable formulation of a solution containing indacaterol maleate and glycopyrronium bromide
|
|
US2020368214A1
|
|
Inhalable formulation of a solution containing vilanterol trifenatate and umeclidinium bromide
|
|
US2020324064A1
|
|
Inhalation Device for Administering Powdered Pharmaceutical Composition
|
|
US2019030268A1
|
|
Inhalation Atomizer Comprising a Blocking Function and a Counter
|
|
US2018344956A1
|
|
Inhaler Device for Administering Powered Pharmaceutical Compositions via Inhalation
|
|
US2008038332A1
|
|
Stable pharmaceutical formulation comprising atorvastatin calcium
|
